Marc DePaul, PhD

Director of Research
NervGen Pharma
Loveland, Ohio, United States

Dr. Marc DePaul is the Director of Research at NervGen Pharma, a Canadian based biotech company dedicated to restoring life’s potential with innovative solutions for nervous system repair. With over 11 years of experience in the biotech industry as a regenerative medicine scientist or consultant, his research strives to identify and develop therapeutics to enhance nervous system repair in disorders and injuries by promoting plasticity, regeneration, and remyelination. He received his Ph.D. in Neurosciences and studied as a post-doc at Case Western Reserve University, where he helped develop the technology NervGen’s platform is founded on.

Presentation(s):

• NVG-291 Phase 1 Results and Phase 1b/2a Study Design in Individuals with Spinal Cord Injury

  Tuesday, October 31, 2023
  4:00 PM – 4:15 PM